Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 37,784 | 37,159 | 29,513 |
| Marketable Securities | 189,003 | 260,009 | 68,349 |
| TOTAL | $230,310 | $300,853 | $100,204 |
| Non-Current Assets | |||
| PPE Net | 14,595 | 7,298 | 5,512 |
| Other Non-Current Assets | 19,980 | 18,030 | 16,639 |
| TOTAL | $34,575 | $25,328 | $22,151 |
| Total Assets | $264,885 | $326,181 | $122,355 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,737 | 1,918 | 957 |
| Accrued Expenses | 9,522 | 6,331 | 3,752 |
| TOTAL | $31,236 | $18,822 | $6,237 |
| Non-Current Liabilities | |||
| Deferred Revenues | 18,662 | 9,277 | N/A |
| Other Non-Current Liabilities | 10,233 | 10,714 | 12,374 |
| TOTAL | $46,389 | $61,753 | $12,374 |
| Total Liabilities | $77,625 | $80,575 | $18,611 |
| Shareholders' Equity | |||
| Retained earnings | -156,564 | -92,833 | -48,853 |
| Other shareholders' equity | 333,451 | 333,533 | 150,132 |
| TOTAL | $187,260 | $245,606 | $103,744 |
| Total Liabilities And Equity | $264,885 | $326,181 | $122,355 |